Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
OMNI BIO PHARMACEUTICAL, INC.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC | |
OMNI BIO PHARMACEUTICAL, INC.Listing unverified | Buy | n/a (No price was disclosed in the filing) | conv 52ClusterFirst in 12mo | SEC |